This white paper highlights the challenges of emerging and re-emerging infectious diseases such as TB, MSSA/MRSA, and Ebola. At Q2 Solutions, we support infectious disease clinical trials with a...
Q2 Solutions’ infectious disease expertise, coupled with that of parent organizations IQVIA and Quest Diagnostics, offers extensive diagnostic testing experience, global CRO expertise and multiple...
Dr. Patrice Hugo recently co-authored a white paper with IQVIA about restarting clinical trials in Asia Pacific following the COVID-19 pandemic. The recent restrictions imposed by many countries in...
